This site uses cookies to store information on your computer. I'm fine with this Cookie information
Follow is on Twitter Like us on Facebook Follow us on Instagram
CORONAVIRUS (COVID-19)

*UPDATED* Hospital visiting changes, home testing kits, Vaccine info, general info and guidance for public, NHSGGC staff, and community-based services.

Covid-19 and Rheumatology

General Information

For the most up to date information on Covid-19, please go to NHSGGC: Covid-19

Coronavirus (Covid-19): Changes to screening tests and appointments


Covid-19 Rheumatology Update - 05/01/2020

Covid-19 Vaccine

All of the proposed Covid-19 vaccines at present are suitable for patients who are receiving immunosuppressive treatment and we would strongly recommend that patients on treatment for Rheumatic conditions accept the Covid-19 vaccine when offered (unless there are other contraindications).

Treatments do not need to be withheld or altered before or after the vaccine. The only exception to this is patients on treatment with Rituximab. The British Society for Rheumatology has recommended ideally a 4-week gap between receiving the vaccine and treatment with rituximab if clinically appropriate. Each rheumatology unit will discuss this with patients who fall into this category. 

Further information can be found on the BSR website: https://www.rheumatology.org.uk/practice-quality/covid-19-guidance

 

NPT guidance

A reminder the Covid modified NPT guidance remains in place until a further review in February 2021. If clinically indicated, patients can and should have additional monitoring and this guidance only applies to patients whose blood monitoring is stable.

The guidance on modified NPT monitoring during Covid-19 can be found here: https://www.nhsggc.org.uk/media/259584/covid-modified-npt-monitoring-agreement_26032020.pdf

 

Previous shielding patients and those who are clinical extremely vulnerable 

Some patients attending Rheumatology clinics will fall into the above categories. There is information on the BSR website (link above) and Scottish Specific information can be found on the Health Protection Scotland Website- Process for identification of patients on immunosuppressive therapy at highest risk of Covid-19 exposure (page 17 appendix 4- Immunosuppression flowchart) 

https://hpspubsrepo.blob.core.windows.net/hps-website/nss/3008/documents/1_covid-19-search-criteria-highest-risk-patients.pdf 

 


Covid-19 and Rheumatology Information

Covid-19 Patient Information Leaflet for people with Rheumatic Conditions

Modified NPT monitoring during Covid-19

Guidance for Rheumatology patients receiving DMARD, Biologic and/or steroid medication during the Covid-19 outbreak and updated blood monitoring schedule

 


Return to Rheumatology MCN Homepage

Last Updated: 05 January 2021